Janux Therapeutics Inc (JANX)

Jan 27, 2025

Thomas Barnes named CEO of Averna - BioCentury

Jan 27, 2025

Jan 27, 2025

Advanced Renal Cell Carcinoma Pipeline 2024: Comprehensive - openPR

Jan 27, 2025

Jan 26, 2025

How to Take Advantage of moves in (JANX) - Stock Traders Daily

Jan 26, 2025

Jan 24, 2025

Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer - BioSpace

Jan 24, 2025

Jan 24, 2025

Janux Therapeutics, Inc. Promotes Zachariah McIver to Chief Medical Officer -January 24, 2025 at 04:01 pm EST - Marketscreener.com

Jan 24, 2025

Jan 24, 2025

Janux Therapeutics Names McIver as Chief Medical Officer - MarketWatch

Jan 24, 2025

Jan 24, 2025

Janux Therapeutics Appoints Former Amgen Director as Chief Medical Officer - StockTitan

Jan 24, 2025

Jan 24, 2025

Janux Therapeutics (NASDAQ:JANX) Trading 6.2% HigherHere's What Happened - MarketBeat

Jan 24, 2025

Jan 22, 2025

Cantor Fitzgerald Predicts JANX FY2025 Earnings - MarketBeat

Jan 22, 2025

Jan 21, 2025

Janux Therapeutics surges amid report of takeover interest - MSN

Jan 21, 2025

Jan 20, 2025

Short Interest in Janux Therapeutics, Inc. (NASDAQ:JANX) Rises By 19.8% - MarketBeat

Jan 20, 2025

Jan 18, 2025

Janux Therapeutics (NASDAQ:JANX) Trading Down 3.5%Time to Sell? - MarketBeat

Jan 18, 2025

Jan 16, 2025

Long Term Trading Analysis for (JANX) - Stock Traders Daily

Jan 16, 2025

Jan 15, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Down 3.5%Time to Sell? - MarketBeat

Jan 15, 2025

Jan 15, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Jan 15, 2025

Jan 10, 2025

JANX Makes Notable Cross Below Critical Moving Average - Nasdaq

Jan 10, 2025

Jan 10, 2025

BTIG affirms Buy on Janux stock, noting competitive positioning of JANX007 in mCRPC - Investing.com Canada

Jan 10, 2025

Jan 10, 2025

Janux Therapeutics (NASDAQ:JANX) Given "Outperform" Rating at William Blair - MarketBeat

Jan 10, 2025

Jan 10, 2025

Cancer data drive significant biopharma stock gains in a volatile 2024 - BioWorld Online

Jan 10, 2025

Jan 08, 2025

Insider Selling: Janux Therapeutics, Inc. (NASDAQ:JANX) CEO Sells 5,000 Shares of Stock - MarketBeat

Jan 08, 2025

Jan 08, 2025

Janux Therapeutics CEO David Campbell sells $300,004 in stock By Investing.com - Investing.com Canada

Jan 08, 2025

Jan 08, 2025

Janux Therapeutics CEO David Campbell sells $300,004 in stock - Investing.com India

Jan 08, 2025

Jan 08, 2025

Vir Scores In Oncology Pivot With Strong Early T-Cell Engager Results - Citeline News & Insights

Jan 08, 2025

Jan 08, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Down 6.8%Here's Why - MarketBeat

Jan 08, 2025

Jan 08, 2025

Janux Therapeutics: mCRPC TAM And Promising JANX007’s Phase 1 Data (NASDAQ:JANX) - Seeking Alpha

Jan 08, 2025

Jan 07, 2025

Janux Therapeutics (NASDAQ:JANX) Trading Up 7%Still a Buy? - MarketBeat

Jan 07, 2025

Jan 05, 2025

Objective long/short (JANX) Report - Stock Traders Daily

Jan 05, 2025

Jan 03, 2025

Insider Selling: Janux Therapeutics, Inc. (NASDAQ:JANX) Insider Sells 13,334 Shares of Stock - MarketBeat

Jan 03, 2025

Jan 03, 2025

Janux Therapeutics chief business officer sells $731,785 in stock By Investing.com - Investing.com Canada

Jan 03, 2025

Jan 03, 2025

Viking Therapeutics among potential buyout candidates: Oppenheimer - MSN

Jan 03, 2025

Jan 03, 2025

Viking stock among buyout targets: Oppenheimer (VKTX:NASDAQ) - Seeking Alpha

Jan 03, 2025

Dec 30, 2024

Janux Therapeutics, Inc. (NASDAQ:JANX) Short Interest Update - MarketBeat

Dec 30, 2024

Dec 28, 2024

Lifesci Capital Upgrades Janux Therapeutics (NASDAQ:JANX) to Strong-Buy - MarketBeat

Dec 28, 2024

Dec 27, 2024

Janux Therapeutics, Inc. (NASDAQ:JANX) CEO Sells $1,404,750.00 in Stock - MarketBeat

Dec 27, 2024

Dec 27, 2024

Janux therapeutics CEO David Campbell sells $1.4 million in stock By Investing.com - Investing.com Nigeria

Dec 27, 2024

Dec 27, 2024

Janux therapeutics CEO David Campbell sells $1.4 million in stock - Investing.com

Dec 27, 2024

Dec 27, 2024

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Geode Capital Management LLC - MarketBeat

Dec 27, 2024

Dec 25, 2024

How the (JANX) price action is used to our Advantage - Stock Traders Daily

Dec 25, 2024

Dec 21, 2024

StockWatch: Wall Street’s Leaders and Laggards of 2024 - Genetic Engineering & Biotechnology News

Dec 21, 2024

Dec 21, 2024

Wellington Management Group LLP Trims Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Dec 21, 2024

Dec 21, 2024

Analysts Set Janux Therapeutics, Inc. (NASDAQ:JANX) PT at $89.90 - MarketBeat

Dec 21, 2024

Dec 19, 2024

State Street Corp Sells 40,056 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Dec 19, 2024

Dec 18, 2024

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Barclays PLC - MarketBeat

Dec 18, 2024

Dec 17, 2024

Finance Watch: FOPO Surge Continues With Big Offerings From Revolution, NewAmsterdam - Scrip

Dec 17, 2024

Dec 13, 2024

Janux Nets $350M in Stock Sale - San Diego Business Journal

Dec 13, 2024

Dec 12, 2024

Neo Ivy Capital Management Buys Shares of 20,674 Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Dec 12, 2024

Dec 11, 2024

Navigating 10 Analyst Ratings For Janux Therapeutics - Benzinga

Dec 11, 2024

Dec 10, 2024

Charles Schwab Investment Management Inc. Raises Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Dec 10, 2024

Dec 07, 2024

Polar Asset Management Partners Inc. Buys New Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Dec 07, 2024

Dec 07, 2024

Point72 Asset Management L.P. Boosts Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Dec 07, 2024